ClearPoint Neuro Inc CLPT
About Quantitative Ratings
Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.
News
Trading Information
- Previous Close Price
- $11.21
- Day Range
- $11.03–11.28
- 52-Week Range
- $4.05–13.47
- Bid/Ask
- $11.06 / $11.26
- Market Cap
- $307.97 Mil
- Volume/Avg
- 9,649 / 197,208
Key Statistics
- Price/Earnings (Normalized)
- —
- Price/Sales
- 10.20
- Dividend Yield (Trailing)
- 0.00%
- Dividend Yield (Forward)
- 0.00%
- Total Yield
- —
Company Profile
ClearPoint Neuro Inc is a medical device company based in the United States. It develops and commercializes platforms for performing minimally invasive surgical procedures in the brain and heart under direct, intra-procedural magnetic resonance imaging (MRI) guidance. The company's ClearPoint system, which is in commercial use, is used to perform minimally invasive surgical procedures in the brain. The company's products include the ClearPoint system, ClearPoint Services, and ClearPoint Therapeutic Solutions.
- Sector
- Healthcare
- Industry
- Medical Devices
- Stock Style Box
- Small Growth
- Total Number of Employees
- 107
- Website
- https://www.clearpointneuro.com
Comparables
Valuation
|
Metric
|
CLPT
|
SIBN
|
688277
|
|---|---|---|---|
Price/Earnings (Normalized) | — | — | — |
Price/Book Value | 9.63 | 3.52 | 3.29 |
Price/Sales | 10.20 | 3.78 | 21.20 |
Price/Cash Flow | — | — | — |
Price/Earnings
CLPT
SIBN
688277
Financial Strength
|
Metric
|
CLPT
|
SIBN
|
688277
|
|---|---|---|---|
Quick Ratio | 2.18 | 7.99 | 2.11 |
Current Ratio | 2.79 | 9.17 | 2.75 |
Interest Coverage | — | −12.97 | −15.62 |
Quick Ratio
CLPT
SIBN
688277
Profitability
|
Metric
|
CLPT
|
SIBN
|
688277
|
|---|---|---|---|
Return on Assets (Normalized) | −24.04% | −6.03% | −13.35% |
Return on Equity (Normalized) | −41.45% | −8.10% | −17.03% |
Return on Invested Capital (Normalized) | −29.10% | −8.97% | −14.15% |
Return on Assets
CLPT
SIBN
688277
Medical Devices Industry Comparables
|
1-Day Chart
|
Name
|
Price
|
Morningstar Rating for Stocks
|
Capital Allocation
|
Economic Moat
|
Market Cap
|
|---|---|---|---|---|---|---|
| Abbott Laboratories
ABT
| Sxvyvcsk | Kcmhhs | $198.4 Bil | |||
| Stryker Corp
SYK
| Lsrvgydy | Qtz | $137.7 Bil | |||
| Boston Scientific Corp
BSX
| Zznkdlk | Qjgql | $123.4 Bil | |||
| Medtronic PLC
MDT
| Dpfrdvdrk | Djmnzp | $115.5 Bil | |||
| Edwards Lifesciences Corp
EW
| Fjdqyllbg | Kshvsl | $39.8 Bil | |||
| Koninklijke Philips NV ADR
PHG
| Xjcn | Bhf | $30.6 Bil | |||
| DexCom Inc
DXCM
| Ydckwhkrv | Vbqh | $26.9 Bil | |||
| Steris PLC
STE
| Zrygrhx | Sqwnchy | $23.9 Bil | |||
| Zimmer Biomet Holdings Inc
ZBH
| Qtbqmwvw | Fjrn | $22.0 Bil | |||
| Insulet Corp
PODD
| Qgpqkccdh | Tldlkdj | $16.3 Bil |
United States